FIELD: medicine.
SUBSTANCE: invention represents a hypotensive means, which contains felodipinum as an active component, as well as target additional components: mesoporous silicon dioxide, lactose, hypromeloza. Realisation of the invention ensures the high technological efficiency of the claimed medical means production with the provision of a prolonged release of an active substance with the application of available components. Felodipinum is included into spherical particles with a highly developed mesoporous structure of silicon oxide.
EFFECT: increase of stability in storage and protection from unfavorable environmental factors.
4 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GRANULATING METHOD | 2014 |
|
RU2585023C1 |
| PROLONGED ANTIHYPERTENSION PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2012 |
|
RU2543637C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURE OF ORAL THERAPEUTIC AGENT FOR PREVENTION AND/OR TREATMENT OF HIV INFECTION | 2021 |
|
RU2759544C1 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| SOLID MEDICINAL FORM INTENDED FOR TREATMENT OF ARTERIAL HYPERTENSIA AND STENOCARDIA, AND WAY OF ITS RECEPTION | 2008 |
|
RU2359672C1 |
| GALENICAL PREPARATIONS OF ORGANIC COMPOUNDS | 2010 |
|
RU2535090C2 |
| SOLID TABLETS AND CAPSULES OF MODIFIED RELEASE OF BENZONATATE | 2014 |
|
RU2673239C2 |
| METHOD FOR PRODUCTION OF SOLID DISPERSE SYSTEM WITH SILICON DIOXIDE | 2015 |
|
RU2595846C1 |
| SUSTAINED-ACTION PHARMACEUTICAL COMPOSITION FOR TREATING HEART DISEASES | 2011 |
|
RU2464018C1 |
| GLUCOSAMINE PROLONGED RELEASE DOSAGE FORM | 2011 |
|
RU2521231C2 |
